| 2004 |
Crystal structure and mutational analysis of BMP-2 bound to BMPR-IA (BRIA) revealed that the main chain atoms of Leu51 and Asp53 of BMP-2 form a hot-spot interface with BRIA. The L51P variant selectively abolished type I receptor binding while preserving type II receptor binding and noggin binding, converting BMP-2 into a receptor-inactive noggin inhibitor. |
X-ray crystallography, site-directed mutagenesis, binding assays |
Nature structural & molecular biology |
High |
15064755
|
| 2008 |
BMP2 regulates Osterix expression through two parallel pathways in mesenchymal cells: a Runx2-dependent pathway and a Runx2-independent pathway involving Smad1/Smad4 and Msx2. Smad6 overexpression suppressed BMP2-induced Osterix in Runx2-null cells; Msx2 knockdown blocked BMP2-induced Osterix in Runx2-deficient cells. |
Genetic (Runx2-/- cells), overexpression/knockdown, reporter assays, microarray |
The Journal of biological chemistry |
High |
18703512
|
| 2005 |
Conditional deletion of Bmp2 in AV myocardium demonstrated that Bmp2 is required for (1) Has2-dependent cardiac jelly formation, (2) endocardial epithelial-to-mesenchymal transition via induction of Twist1, Msx1, and Msx2, and (3) AV myocardial patterning via Tbx2 expression. Endocardial-specific deletion of Bmpr1a also abrogated cushion formation, placing Bmp2 signaling directly to endocardium through BMPR1A. |
Conditional knockout (Cre-lox), in situ hybridization, genetic epistasis |
Development (Cambridge, England) |
High |
16314491
|
| 2008 |
BMP2 stimulation of C2C12 cells induces actin cytoskeleton rearrangement and cell migration through independent and parallel activation of Cdc42 GTPase and PI3K-alpha. BMP2 also activates PAK isoforms and LIMK1 in a PI3K-dependent manner. |
Dominant-negative Cdc42 overexpression, pharmacological PI3K inhibitors, kinase activity assays, phospho-specific antibodies |
Journal of cell science |
Medium |
19001503
|
| 2016 |
In developing mouse neocortex, BMP2 activates YAP, and nuclear/active YAP is required for SMAD1 stabilization and subsequent astrocytic differentiation. Expression of SMAD1 in YAP-deficient NSCs partially rescued astrocytic differentiation deficits, placing YAP between BMP2 receptor activation and SMAD1 stability. |
Conditional knockout (Nestin-Cre; GFAP-Cre), co-immunoprecipitation, rescue experiments, immunofluorescence |
Development (Cambridge, England) |
Medium |
27381227
|
| 2016 |
Angiocrine Bmp2 from liver sinusoidal endothelial cells (LSECs) is required for normal iron homeostasis. LSEC-specific Bmp2 deletion (Stab2-Cre;Bmp2fl/fl) caused massive hepatic iron overload, decreased hepcidin expression, and systemic iron elevation, demonstrating a non-redundant pathway distinct from Bmp6. |
Conditional knockout (Stab2-Cre), serum/tissue iron measurements, hepcidin expression analysis |
Blood |
High |
27903529
|
| 2009 |
PI3K-Akt signaling is required downstream of BMP2 for osteoblast differentiation. Dominant-negative Akt or PI3K inhibitors blocked BMP2-induced osteoblast differentiation without affecting Smad-responsive genes (Sox9, JunB), while activated Akt restored differentiation blocked by IGFBP5 or PI3K inhibition. |
Dominant-negative Akt, adenoviral activated Akt, pharmacological inhibitors, metatarsal organ culture |
Journal of cell science |
Medium |
19208758
|
| 2003 |
BMP2 exposure increases PTEN protein levels in MCF-7 cells by decreasing PTEN protein degradation rather than increasing synthesis (cycloheximide did not block accumulation). BMP2 treatment decreased PTEN association with ubiquitin-conjugating enzymes UbCH7 and UbC9. |
Western blot, cycloheximide chase, co-immunoprecipitation with ubiquitin pathway components |
Human molecular genetics |
Medium |
12620973
|
| 2011 |
BMP2 activates ATF6 transcription through Runx2-dependent direct binding to the OSE2 motif (-205 to -200 bp) in the Atf6 promoter. ATF6 in turn directly binds the osteocalcin (Oc) promoter to induce osteocalcin expression; dominant-negative ATF6 blocked BMP2- and Runx2-induced osteocalcin expression. ATF6 activation by BMP2 was absent in Runx2-/- primary osteoblasts. |
ChIP, promoter-reporter assays, dominant-negative constructs, Runx2-/- primary cells |
The Journal of biological chemistry |
High |
22102412
|
| 2005 |
Runx2 is required for FGF2-induced Bmp2 expression during cranial bone development. Disruption of Runx2 abolished Bmp2, Dlx5, and Msx2 expression in developing bone primordium while Fgf2 expression was maintained. FGF2 could not induce Bmp2 in Runx2-/- cells, but Runx2 transfection restored FGF2-dependent Bmp2 induction. |
Runx2-/- mouse tissue analysis, cell transfection, in situ hybridization |
Developmental dynamics |
Medium |
15765505
|
| 2001 |
BMP2-induced neurite outgrowth in PC12 cells requires TAK1 kinase upstream of p38 MAPK. Inhibitory Smads (Smad6 and Smad7) physically interact with TAB1 (TAK1-binding protein) and suppress the TAK1-p38 pathway, thereby inhibiting BMP2-induced neurite outgrowth. |
Dominant-negative TAK1, Smad6/7 overexpression, co-immunoprecipitation (Smad6/7 with TAB1), neurite outgrowth assay |
Genes to cells |
Medium |
11737269
|
| 2011 |
BMP2 regulates expression of BMP antagonists Gremlin1 and Gremlin2 in opposite directions during osteoblast differentiation: Gremlin1 is downregulated while Gremlin2 is upregulated in a time- and dose-dependent manner. BMP2-induced Gremlin2 expression requires Smad4 and p38 MAPK signaling. |
DNA microarray, Smad4 siRNA, p38 MAPK inhibitor (SB203580), dose/time-response assays |
Calcified tissue international |
Medium |
22644325
|
| 2011 |
BMP2 induces apoptosis in osteoblast lineage cells in a maturation-state-dependent manner, with robust effects in mature osteoblasts (NHOst) but minor effects in MSCs. BMP2-induced apoptosis in committed osteoblasts is mediated through both Smad and TAB/TAK1 signaling pathways and is negatively regulated by Noggin. |
Caspase-3, BAX/BCL2, p53, DNA fragmentation assays; BMP signaling inhibitors (dorsomorphin, 5Z-7-oxozeaenol, H-8); Noggin knockdown |
Journal of cellular biochemistry |
Medium |
22628200
|
| 2019 |
BMP7 functions predominantly as a heterodimer with BMP2 or BMP4 during mammalian embryogenesis. Knock-in mice carrying a Bmp7 mutation preventing proteolytic activation eliminated BMP7 homodimer and BMP7-containing heterodimer function; compound heterozygotes with Bmp7 and Bmp2-null alleles died during embryogenesis. Co-immunoprecipitation confirmed endogenous BMP4/7 heterodimers exist in vivo. |
Knock-in mouse genetics, genetic epistasis (compound heterozygotes), co-immunoprecipitation of endogenous proteins |
eLife |
High |
31566563
|
| 2016 |
Canonical Wnt signaling requires Bmp2 to specify osteoblast cell fate. Bmp2-deficient limb bud or bone marrow progenitors fail to progress through the Runx2/Osx1 checkpoint in response to Wnt stimulation. Cells lacking Bmp2 only after Osx1 induction differentiate normally, identifying pre-Osx1+ progenitors as both the source and target of BMP2. Grhl3 transcription factor acts downstream of BMP2 and upstream of Osx1. |
Conditional knockout, genetic epistasis, gene expression analysis |
Development (Cambridge, England) |
High |
27802170
|
| 2009 |
Bmp2 and Bmp4 exert opposing roles in hypoxic pulmonary hypertension. Bmp2(+/-) mice develop more severe hypoxic PH than wild-type, associated with reduced eNOS expression and activity in pulmonary vasculature. Exogenous BMP2 upregulates eNOS expression and activity in pulmonary artery and endothelial cell preparations, identifying eNOS as a target of Bmp2 signaling. |
Heterozygous null mouse model, eNOS expression/activity assays, ex vivo BMP2 treatment |
American journal of physiology. Regulatory, integrative and comparative physiology |
Medium |
20042692
|
| 2011 |
Conditional deletion of Bmp2 in early-polarizing odontoblasts (3.6Col1a1-Cre) impaired odontoblast maturation and dentin formation, with decreased Osterix, Col1a1, and Dspp expression. Bmp2 in odontoblasts also indirectly controls pulp vascular bed formation and pericyte numbers via VegfA production. |
Conditional knockout (Cre-lox), immunohistochemistry, gene expression analysis |
Journal of dental research |
Medium |
21984706
|
| 2011 |
Conditional deletion of Bmp2 (with Bmp4) in dental epithelium (Osx-Cre) caused enamel hypomineralization, loss of prismatic architecture, and incisor defects. Double epithelial Bmp2/Bmp4 knockout demonstrated that BMP/Smad4 signaling in ameloblasts controls MMP20 and KLK4 expression required for enamel matrix processing. |
Conditional knockout, SEM, microradiography, qRT-PCR, histology |
Cells, tissues, organs / Scientific reports |
Medium |
21597270 27146352
|
| 2011 |
PTH-CREB signaling pathway activates BMP2 transcription in osteoblasts via a specific CRE element in the BMP2 promoter. ChIP and EMSA confirmed direct CREB binding to this promoter element; genetic/pharmacological modulation of PTH-CREB activity proportionally affected BMP2 expression. |
ChIP, EMSA, promoter-reporter deletion/mutation assays, siRNA, pharmacological modulation |
PloS one |
Medium |
21695256
|
| 2010 |
Adiponectin increases BMP-2 expression in osteoblasts via AdipoR1 receptor signaling through sequential activation of AMPK, p38, and NF-κB pathways. AMPK siRNA and inhibitors, p38 inhibitors, and NF-κB pathway inhibitors each attenuated adiponectin-induced BMP-2 expression. |
siRNA knockdown, pharmacological pathway inhibitors, Western blot, ELISA, qRT-PCR |
Journal of cellular physiology |
Medium |
20432444
|
| 2012 |
BMP2 and mechanical loading cooperatively regulate BMP signaling by enhancing the intensity and duration of R-Smad phosphorylation. Mechanical signals integrate directly into the BMP pathway at a step upstream of Smad phosphorylation, independent of autocrine BMP2 secretion, suggesting crosstalk at cell-surface receptor level. |
3D bioreactor system, time-course phosphorylation assays (Smad, MAPK, Akt), BMP target gene transcription analysis |
BMC biology |
Medium |
22540193
|
| 2021 |
Osteomodulin (OMD) binds directly to BMP2 via its terminal leucine-rich repeats and forms complexes with BMP2 and BMP2 membrane receptors, promoting BMP/SMAD signal transduction and osteogenesis. OMD is itself a target gene of SMAD4 in this pathway. |
Co-immunoprecipitation (pulldown), in vitro osteogenesis assays, in vivo bone defect model, gene knockdown |
Cell death & disease |
Medium |
33542209
|
| 2009 |
GDF5 and BMP2 prevent apoptosis in mouse embryonic fibroblasts via BMPR2, which stabilizes XIAP by stimulating BMPR2-XIAP interaction and reducing XIAP ubiquitination. This anti-apoptotic mechanism is independent of Smad and MAPK signaling. |
Co-immunoprecipitation (BMPR2-XIAP), ubiquitination assay, apoptosis assays, signaling pathway inhibitors |
Biochimica et biophysica acta |
Medium |
19782107
|
| 2010 |
Agrin N-terminal domain binds BMP2 (and BMP4, TGFβ1) with Kd in the 10-100 nM range as measured by surface plasmon resonance, and inhibits BMP2 activity in reporter assays with IC50 ~500 nM. |
Surface plasmon resonance (SPR), reporter assay |
PloS one |
Medium |
20505824
|
| 2013 |
Progastrin suppresses BMP2 transcription through a CCK2R- and β-arrestin 1/2-dependent pathway in colonic epithelial cells, leading to decreased Smad1/5/8 phosphorylation and suppression of Id4. Recombinant BMP2 blocked progastrin-induced proliferation and symmetric cell division. |
Microarray, siRNA (β-arrestin 1/2), CCK2R knockout, recombinant BMP2 rescue, colonic crypt cultures |
Gastroenterology |
Medium |
23891976
|
| 2018 |
Ectopic myocardial Bmp2 expression in mice induces endocardial EMT via Notch1 activation, mediated by Bmp2-driven transcriptional induction of Notch ligand Jag1 and physical interaction between Smad1/5 and the intracellular domain of Notch1 receptor. |
Transgenic mouse model, biochemical interaction assay (Smad1/5 - Notch1 ICD), gene expression profiling, in vitro EMT assay |
Development (Cambridge, England) |
Medium |
29853617
|
| 2015 |
BMP2-induced fracture healing requires tight temporal and spatial control of CXCL12 expression. BMP2 induces osteoblastic differentiation of endosteal cells while decreasing CXCL12 expression. Loss of BMP2 in mesenchymal osteoprogenitors causes dysregulated CXCL12 upregulation; blocking CXCR4 (AMD3100) rescued healing in BMP2-deficient mice. |
Conditional knockout, AMD3100 pharmacological rescue, MSC transplantation, in vitro differentiation assays |
Journal of bone and mineral research |
Medium |
25967044
|
| 2019 |
PDGF signaling through PDGFRβ inhibits BMP2-induced osteogenesis in periosteal progenitor cells by suppressing the canonical BMP2/Smad pathway and downstream target gene expression. This inhibitory effect is mediated via ERK1/2 MAPK and PI3K/AKT signaling. |
In vitro differentiation assays, pharmacological pathway inhibitors, gene expression analysis, PDGFRβ-targeted experiments |
JBMR plus |
Medium |
31131345
|
| 2009 |
Elevated intracellular cAMP enhances BMP2-induced osteoblastic differentiation in C2C12 cells by increasing BMP2-induced MKP1 expression and suppressing Erk1/2 phosphorylation and cell proliferation downstream of BMP2. |
Pharmacological cAMP elevation (Forskolin, dbcAMP, IBMX), kinase phosphorylation assays, alkaline phosphatase activity |
Biochemical and biophysical research communications |
Low |
19217886
|
| 2010 |
BMP2 signals through BMPR2 and BMPR1A (ALK3) and intracellular SMADs 1 and 5 to stimulate Id3 transcription in murine gonadotropes. A novel proximal 6-bp cis-element and a more distal enhancer element in the Id3/ID3 promoter each mediate BMP2/SMAD-dependent transcription. |
Promoter-reporter deletion/mutation assays, RNAi knockdown of receptors and SMADs, qRT-PCR |
Molecular and cellular endocrinology |
Medium |
21056086
|
| 2004 |
Post-transcriptional regulation of Bmp2 mRNA is conserved across vertebrates. A 265-nt element in the Bmp2 3'UTR, absent from Bmp4, stabilizes Bmp2 mRNA in a cell-type-specific manner. Bmp2 synthetic RNAs decay rapidly in extracts from cells not expressing Bmp2 but are stable in Bmp2-expressing cells, indicating cell-context-dependent RNA decay machinery interactions. |
In vitro RNA decay assays, reporter gene activation by 3'UTR fragments, evolutionary sequence conservation analysis |
The Journal of biological chemistry |
Medium |
15358784
|
| 2019 |
Fenofibrate increases BMP2 expression in osteoblasts via PPARα-mediated direct binding to the BMP2 promoter. PPARα knockdown abolished fenofibrate-induced BMP2 expression; ChIP confirmed PPARα occupancy at the BMP2 promoter upon fenofibrate treatment. |
ChIP, siRNA knockdown, promoter-reporter assay, qRT-PCR |
Biochemical and biophysical research communications |
Medium |
31607484
|
| 2011 |
BMP-2 induction of cell migration in AV cushion mesenchyme requires signaling through BMPR-1B (ALK6). BMP-2 induces periostin expression (at mRNA and protein levels) and Twist and Id1 transcription; these effects are blocked by noggin or dominant-negative BMPR-1B. |
3D-collagen gel culture, constitutively active and dominant-negative viral constructs, noggin antagonism, migration assays, in situ hybridization |
Developmental biology |
Medium |
18261719
|
| 2020 |
BMP2 upregulates IGFBP3 expression in human endometrial stromal cells via ALK3 receptor → ID1 → IGFBP3 cascade. Knockdown of ALK3 abolished BMP2-induced ID1 upregulation; knockdown of IGFBP3 or ID1 suppressed BMP2-induced MMP2 expression and cell migration. |
siRNA knockdown (ALK3, ID1, IGFBP3), dose/time-response, Western blot, migration assay in primary and immortalized cells |
FASEB journal |
Medium |
32975335
|
| 2022 |
BMP2 promotes lung adenocarcinoma metastasis via BMPR2-mediated SMAD1/5/8 pathway activation, independent of KRAS signaling. Depletion of BMP2 or BMPR2 reduced cell migration/invasiveness; SMAD1/5/8 depletion or LDN193189 inhibition blocked BMP2-induced migration. Orthotopic mouse model confirmed BMP2's pro-metastatic role in vivo. |
siRNA knockdown, LDN193189 inhibitor, orthotopic mouse model, migration/invasion assays |
Scientific reports |
Medium |
36175474
|
| 2024 |
Heparan sulfate (HS) promotes BMP2 signaling in the extracellular space while chondroitin sulfate enhances BMP2 bioactivity at the cell surface. HS binding to BMP2 involves a central IdoA(2S)-GlcNS(6S) tri-sulfated motif; BMP2 shows adaptability to various HS sulfation types due to N-terminal end flexibility (from molecular dynamics simulations). Co-immobilization of HS with cRGD enhanced BMP2-mediated SMAD1/5/9 phosphorylation and osteogenic differentiation. |
Biomimetic surface platforms, SMAD1/5/9 phosphorylation assays, integrin silencing, molecular dynamics simulations |
Carbohydrate polymers |
Medium |
38876708
|